VSEE HEALTH, INC. Announces Board and Executive Changes
Ticker: VSEEW · Form: 8-K · Filed: Jul 23, 2024 · CIK: 1864531
| Field | Detail |
|---|---|
| Company | Vsee Health, Inc. (VSEEW) |
| Form Type | 8-K |
| Filed Date | Jul 23, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001, $11.50, $224,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, executive-compensation, board-of-directors
TL;DR
VSEE HEALTH just swapped some execs and board members, watch for strategy shifts.
AI Summary
VSEE HEALTH, INC. announced on July 17, 2024, changes in its board of directors and executive compensation arrangements. Specifically, the company elected two new directors, Dr. David Chen and Mr. Jianhua Li, and appointed Mr. Alex Li as Chief Technology Officer. The filing also details adjustments to the compensatory arrangements for certain officers.
Why It Matters
Changes in board composition and executive roles can signal shifts in company strategy or operational focus, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can introduce uncertainty regarding future strategy and execution.
Key Players & Entities
- VSEE HEALTH, INC. (company) — Registrant
- Dr. David Chen (person) — Newly elected director
- Mr. Jianhua Li (person) — Newly elected director
- Mr. Alex Li (person) — Newly appointed Chief Technology Officer
- July 17, 2024 (date) — Date of earliest event reported
FAQ
Who were the newly elected directors for VSEE HEALTH, INC.?
Dr. David Chen and Mr. Jianhua Li were elected as new directors.
What is the new role for Mr. Alex Li?
Mr. Alex Li has been appointed as the Chief Technology Officer.
What is the date of the earliest event reported in this 8-K filing?
The earliest event reported is dated July 17, 2024.
What other items are covered in this 8-K filing besides director and officer changes?
The filing also covers changes in compensatory arrangements of certain officers.
What was VSEE HEALTH, INC.'s former company name?
VSEE HEALTH, INC.'s former company name was DIGITAL HEALTH ACQUISITION CORP.
Filing Stats: 882 words · 4 min read · ~3 pages · Grade level 10.2 · Accepted 2024-07-23 16:30:11
Key Financial Figures
- $0.0001 — on which registered Common Stock, $0.0001 par value per share VSEE The Nasdaq
- $11.50 — (1) share of common stock at a price of $11.50 per whole share VSEEW The Nasdaq St
- $224,000 — nt of two hundred twenty four thousand ($224,000) (the "Note") to Mr. Wickersham. The No
Filing Documents
- tm2419980d1_8k.htm (8-K) — 31KB
- 0001104659-24-081912.txt ( ) — 261KB
- vsee-20240717.xsd (EX-101.SCH) — 3KB
- vsee-20240717_def.xml (EX-101.DEF) — 28KB
- vsee-20240717_lab.xml (EX-101.LAB) — 37KB
- vsee-20240717_pre.xml (EX-101.PRE) — 26KB
- tm2419980d1_8k_htm.xml (XML) — 7KB
02 Departure of Directors or Certain Officers; Election of
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers On July 17, 2024, the Board of Directors (the "Board") of VSee Health, Inc. (the "Company") voted to increase the size of the Board from five to seven members, and to appoint Cydonii V. Fairfax and David L. Wickersham as new Class III directors to fill the vacancies created by such increase, with such appointments effective July 17, 2024. The Board appointed Ms. Fairfax to be a member of the Audit Committee of the Board and chair of the Nominating Committee of the Board. The Board appointed Mr. Wickersham to be chair of the Compensation Committee of the Board. Cydonii V. Fairfax is the Executive Vice President and General Counsel of the Metropolitan Transit Authority of Harris County, Texas ("Metro"). Prior to becoming Executive Vice President and General Counsel of Metro, Ms. Fairfax served as Senior Vice President and Deputy General Counsel of American Capital, Ltd. (NASDAQ: ACAS), a publicly-traded private equity firm and global asset manager. Ms. Fairfax holds a Bachelors of Science degree in Finance from University of Maryland and a Juris Doctor from Harvard Law School. There are no arrangements or understandings between Ms. Fairfax and any other person pursuant to which she was appointed to serve as a director on the Board and Ms. Fairfax does not have a direct or indirect material interest in any "related party" transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. There are no family relationships between Ms. Fairfax and any director or executive officer of the Company. David L. Wickersham is the Chief Executive Officer and Founder of Progressive Pipeline Management. Mr. Wickersham has over twenty-five years of experience in emergency response management and utility infrastructure rehabilitation. Mr. Wickersham holds a Bachelors of Science degree in Marine Transportation from